Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Early disease course is unaltered in mucopolysaccharidosis type IIIA (MPS IIIA) mice lacking α‐synuclein.

Autor: Soe, K.^1,2 (AUTHOR), Beard, H.¹ (AUTHOR), Neumann, D.¹ (AUTHOR), Trim, P. J.^1,2 (AUTHOR), Duplock, S.¹ (AUTHOR), Snel, M. F.^1,2 (AUTHOR), Hopwood, J. J.^1,2 (AUTHOR), Hemsley, K. M.^1,2 (AUTHOR) kim.hemsley@sahmri.com

Publikováno v: Neuropathology & Applied Neurobiology. Dec2019, Vol. 45 Issue 7, p715-731. 17p.

Effect of high dose, repeated intra-cerebrospinal fluid injection of sulphamidase on neuropathology in mucopolysaccharidosis type IIIA mice.

Autor: Hemsley, K. M.^1,2 kim.hemsley@adelaide.edu.au, Beard, H.¹, King, B. M.¹, Hopwood, J. J.^1,2

Publikováno v: Genes, Brain & Behavior. Oct2008, Vol. 7 Issue 7, p740-753. 14p. 2 Black and White Photographs, 1 Chart, 5 Graphs.

REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC):a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial

Autor: King, A, Barton, D, Beard, H A, Than, N, Moore, J, Corbett, C, Thomas, J, Guo, K, Guha, I, Hollyman, D, Stocken, D, Yap, C, Fox, R, Forbes, S J, Newsome, P N

Publikováno v: King, A, Barton, D, Beard, H A, Than, N, Moore, J, Corbett, C, Thomas, J, Guo, K, Guha, I, Hollyman, D, Stocken, D, Yap, C, Fox, R, Forbes, S J & Newsome, P N 2015, ' REpeated AutoLogous Infusions of STem cells In Cirrhosis (REALISTIC) : a multicentre, phase II, open-label, randomised controlled trial of repeated autologous infusions of granulocyte colony-stimulating factor (GCSF) mobilised CD133+ bone marrow stem cells in patients with cirrhosis. A study protocol for a randomised controlled trial ', BMJ Open, vol. 5, no. 3, pp. e007700 . https://doi.org/10.1136/bmjopen-2015-007700

INTRODUCTION: Liver disease mortality and morbidity are rapidly rising and liver transplantation is limited by organ availability. Small scale human studies have shown that stem cell therapy is safe and feasible and has suggested clinical benefit. No

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3094::7628613801b0f95b85d56129717ad01b
https://hdl.handle.net/20.500.11820/1236aa3d-0494-40fa-93b8-ab98e3ce49f0

Federal Scientific Research

Autor: Roberts, R. G., Beard, H. H.

Publikováno v: Science, 1945 Dec . 102(2661), 660-660.

Externí odkaz: https://www.jstor.org/stable/1673270